UNSPSC 51422330: Betamethasone succinate

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H33FO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LMR652FZVK. European Medicines Agency schedules betamethasone succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00785MIG. Most nations, for tariff and trade purposes, schedule betamethasone succinate under HS 29372200 and SITC 54153. As of Q4 2014, BETAMETHASONE SUCCINATE remains US FDA's Preferred Term for this commodity.

SMILES: C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)CCC(=O)O)O)C)O)F)C.

UNSPSC 51422330 Betamethasone succinate, a Commodity code, is tagged to state and local pharmaceutical procurement, though recent solicitation activity under this specific code shows minimal alignment with its nominal scope. The code nominally covers a synthetic corticosteroid used in clinical settings, yet the single recent state and local opportunity posted under it—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—falls entirely outside the betamethasone category and suggests either a tagging error or inconsistent code application at the issuing body level. State and local governments use pharmaceutical commodity codes to procure clinical supplies for health departments, county health buildings, and community health initiatives, typically through IFB or RFQ processes with annual terms and renewal options. Issuing bodies at the county and municipal level drive procurement under related pharmaceutical codes, particularly where federal funding such as FEMA reimbursement applies and compliance with federal environmental and workplace standards is required.

The Seminole County opportunity represents the only recent activity indexed under this code. Seminole County, Florida posted the IFB on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, Florida. The contract included a two-year initial term with a one-year renewal option, fixed-fee pricing, and standard compliance requirements including E-Verify and workers' compensation insurance. The mismatch between the code's name and the actual solicitation scope signals that recent state and local activity under UNSPSC 51422330 is either sparse or misclassified; business development professionals should verify code alignment with procurement systems directly rather than rely on this single outlier posting.